Sfoglia per Rivista
A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure?
2007-01-01 DI MARIO, Francesco; Cavallaro, L. G. L.; Nouvenne, Antonio; N., Stefani; Cavestro, Giulia Martina; V., Iori; M., Maino; G., Comparato; Morana, L. F. A. N. I. G. I. U. L. O. E.; A., Pilotto; L., Martelli; M., Martelli; G., Lenadro; A., Franze'
Dual vsTriple Therapy for Childhood Helicobacter pylori Gastritis: a Double-Blind Randomized Multicentre Trial. (I.F. 2.313)
2004-01-01 G., Oderda; D., Mariniello; P., Lerro; M., Kuvidi; DE ANGELIS, Gian Luigi; A., Ferzetti; S., Cucchiara; M. T., Franco; C., Romano; P., Strisciuglio; L., Pensabene
Early epigastric pain after PPI administration: exacerbation of Helicobacter pylori corpus gastritis?
2004-01-01 DI MARIO, Francesco; Ingegnoli, A; DAL BO, N; Cavestro, Giulia Martina; Moussa, Am; Cavallaro, Lg; Aragona, G; Iori, V; Pilotto, A; Franze, A; Rugge, M.
Efficacy of PPIs and H-2 blockers therapy on acid suppression assessed by Gastrin-17 and Pepsinogen I serum levels determination
2017-01-01 Franzoni, L.; Scida, S.; Miraglia, C.; Violi, A.; Corrente, V.; Franceschi, M.; Panozzo, P.; Masciangelo, G.; Tursi, A.; Brandimarte, G.; Di Mario, F.; Scarpignato, C.
Gastric juice polymerase chain reaction: an alternative to histology in the diagnosis of Helicobacter pylori infection
1996-01-01 Basso, D; Navaglia, F; Cassaro, M; Scrigner, M; Toma, A; Dal Bo, N; Di Mario, F; Rugge, M; Plebani, M
Helicobacter pylori infection in children and adults: a single pathogen but a different pathology
2003-01-01 Gallo, N; Zambon, Cf; Navaglia, F; Basso, D; Guariso, G; GRAZIA PIVA, M; Greco, E; Mazza, S; Fogar, P; Rugge, M; DI MARIO, Francesco; Plebani, M.
Helicobacter pylori infection in clinical practice: Probiotics and a combination of probiotics + lactoferrin improve compliance, but not eradication, in sequential therapy.(I.F.3.151)
2012-01-01 Manfredi, M.; Bizzarri, B.; Sacchero, R. I.; Maccari, S.; Calabrese, L.; Fabbian, F.; DE ANGELIS, Gian Luigi
Helicobacter pylori infection: Sequential therapy followed by levofloxacin-containing triple therapy provides a good cumulative eradication rate. (I.F.3.151)
2012-01-01 Manfredi, M.; Bizzarri, B.; DE ANGELIS, Gian Luigi
Helicobacter pyloriand Nonmalignant Diseases
2014-01-01 Enzo, Ierardi; Elisabetta, Goni; Giuseppe, Losurdo; DI MARIO, Francesco
Impact of treatments on fecal microbiota and fecal metabolome in symptomatic uncomplicated diverticular disease of the colon
2017-01-01 Tursi, A.; Mastromarino, P.; Capobianco, D.; Elisei, W.; Laghi, Lucio; Zhu, C.; Picchio, M.; Giorgetti, G.; Fabiocchi, F.; Di Mario, F.; Brandimarte, G.
Interaction between Helicobacter pylori and host genetic variants regulates serum level of pepsinogen II
2017-01-01 De Re, V.; De Zorzi, M.; Caggiari, L.; Magris, R.; Di Mario, F.; Steffan, A.; Canzonieri, V.; Cannizzaro, R.
New bismuth-containing quadruple therapy in patients infected with Helicobacter pylori: A first Italian experience in clinical practice
2017-01-01 Tursi, Antonio; Di Mario, Francesco; Franceschi, Marilisa; De Bastiani, Rudi; Elisei, Walter; Baldassarre, Gianluca; Ferronato, Antonio; Grillo, Simone; Landi, Stefano; Zamparella, Maria; De Polo, Manuela; Boscariolo, Laura; Picchio, Marcello
Non invasive diagnosis of upper GI disease in a primary care setting: A study on 1900 patients
2017-01-01 Di Mario, F.; Cesario, S.; Grillo, S.; Landi, S.; Baldassarre, G.; Cannizzaro, R.; Crafa, P.; Roberti, M.; Riccò, M.; Bertelè, A.; Corrente, V.; Scarpignato, C.; Rugge, M.
Optimal PPI-based triple therapy for the cure of Helicobacter pylori infection: a single center comparison of four 14-day schedules
1998-01-01 Battaglia, G; Di Mario, F; Leandro, G; Benvenuti, M E; Donisi, P M; Vianello, F; Del Bò, N; Pasini, M; Pasquino, M; Vigneri, S
Pepsinogen II in gastritis and Helicobacter pylori infection
2022-01-01 Di Mario, F.; Crafa, P.; Barchi, A.; Franzoni, L.; Franceschi, M.; Russo, M.; Bricca, L.; Brozzi, L.; Rodriguez Castro, K.; Rugge, M.
Practice pattern of gastroenterologists regarding the treatment of Helicobacter pylori infection in Italy
2017-01-01 Zagari, R. M.; Eusebi, L. H.; Rabitti, S.; Annibale, B.; Caselli, M.; Di Mario, F.; Farinati, F.; Franceschi, F.; Gasbarrini, A.; Luzza, F.; Maconi, G.; Nardone, G.; Romano, M.; Vaira, B.; Bazzoli, F.
Raising public awareness of GI disease: An innovative strategy for a national campaign
2017-01-01 Franzoni, L.; Crafa, P.; Bertelè, A.; Corrente, V.; Grillo, S.; Landi, S.; Miraglia, C.; Scida, S.; Di Mario, F.
Reflux esophagitis after H.p. eradication: A comparison between duodenal ulcer patients and control subjects
2017-01-01 DI MARIO, Francesco
Role of homocysteine and chromogranin serum levels in chronic atrophic gastritis: Relationship with aetiology and severity according with olga staging
2017-01-01 Panozzo, M.; Franceschi, M.; Baldassarre, G.; Miraglia, C.; Sella, D.; Antico, A.; Ferronato, A.; Scida, S.; Rugge, M.; Noto, A.; Crafa, P.; Scarpignato, C.; Franzoni, L.; Cannizzaro, R.; Tursi, A.; Di Mario, F.
Serum Pepsinogen II as a non-invasive marker for diagnosis of Helicobacter pylori infection: a prospective study in a cohort of dyspeptic patients
2017-01-01 Di Mario, F.; Miraglia, C.; Scida, S.; Violi, A.; Cesario, S.; Franceschi, M.; Baldassarre, G.; Rugge, M.; Crafa, P.; Tursi, A.; Brandimarte, G.; Franzoni, L.; Cannizzaro, R.; Scarpignato, C.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? | 1-gen-2007 | DI MARIO, Francesco; Cavallaro, L. G. L.; Nouvenne, Antonio; N., Stefani; Cavestro, Giulia Martina; V., Iori; M., Maino; G., Comparato; Morana, L. F. A. N. I. G. I. U. L. O. E.; A., Pilotto; L., Martelli; M., Martelli; G., Lenadro; A., Franze' | |
Dual vsTriple Therapy for Childhood Helicobacter pylori Gastritis: a Double-Blind Randomized Multicentre Trial. (I.F. 2.313) | 1-gen-2004 | G., Oderda; D., Mariniello; P., Lerro; M., Kuvidi; DE ANGELIS, Gian Luigi; A., Ferzetti; S., Cucchiara; M. T., Franco; C., Romano; P., Strisciuglio; L., Pensabene | |
Early epigastric pain after PPI administration: exacerbation of Helicobacter pylori corpus gastritis? | 1-gen-2004 | DI MARIO, Francesco; Ingegnoli, A; DAL BO, N; Cavestro, Giulia Martina; Moussa, Am; Cavallaro, Lg; Aragona, G; Iori, V; Pilotto, A; Franze, A; Rugge, M. | |
Efficacy of PPIs and H-2 blockers therapy on acid suppression assessed by Gastrin-17 and Pepsinogen I serum levels determination | 1-gen-2017 | Franzoni, L.; Scida, S.; Miraglia, C.; Violi, A.; Corrente, V.; Franceschi, M.; Panozzo, P.; Masciangelo, G.; Tursi, A.; Brandimarte, G.; Di Mario, F.; Scarpignato, C. | |
Gastric juice polymerase chain reaction: an alternative to histology in the diagnosis of Helicobacter pylori infection | 1-gen-1996 | Basso, D; Navaglia, F; Cassaro, M; Scrigner, M; Toma, A; Dal Bo, N; Di Mario, F; Rugge, M; Plebani, M | |
Helicobacter pylori infection in children and adults: a single pathogen but a different pathology | 1-gen-2003 | Gallo, N; Zambon, Cf; Navaglia, F; Basso, D; Guariso, G; GRAZIA PIVA, M; Greco, E; Mazza, S; Fogar, P; Rugge, M; DI MARIO, Francesco; Plebani, M. | |
Helicobacter pylori infection in clinical practice: Probiotics and a combination of probiotics + lactoferrin improve compliance, but not eradication, in sequential therapy.(I.F.3.151) | 1-gen-2012 | Manfredi, M.; Bizzarri, B.; Sacchero, R. I.; Maccari, S.; Calabrese, L.; Fabbian, F.; DE ANGELIS, Gian Luigi | |
Helicobacter pylori infection: Sequential therapy followed by levofloxacin-containing triple therapy provides a good cumulative eradication rate. (I.F.3.151) | 1-gen-2012 | Manfredi, M.; Bizzarri, B.; DE ANGELIS, Gian Luigi | |
Helicobacter pyloriand Nonmalignant Diseases | 1-gen-2014 | Enzo, Ierardi; Elisabetta, Goni; Giuseppe, Losurdo; DI MARIO, Francesco | |
Impact of treatments on fecal microbiota and fecal metabolome in symptomatic uncomplicated diverticular disease of the colon | 1-gen-2017 | Tursi, A.; Mastromarino, P.; Capobianco, D.; Elisei, W.; Laghi, Lucio; Zhu, C.; Picchio, M.; Giorgetti, G.; Fabiocchi, F.; Di Mario, F.; Brandimarte, G. | |
Interaction between Helicobacter pylori and host genetic variants regulates serum level of pepsinogen II | 1-gen-2017 | De Re, V.; De Zorzi, M.; Caggiari, L.; Magris, R.; Di Mario, F.; Steffan, A.; Canzonieri, V.; Cannizzaro, R. | |
New bismuth-containing quadruple therapy in patients infected with Helicobacter pylori: A first Italian experience in clinical practice | 1-gen-2017 | Tursi, Antonio; Di Mario, Francesco; Franceschi, Marilisa; De Bastiani, Rudi; Elisei, Walter; Baldassarre, Gianluca; Ferronato, Antonio; Grillo, Simone; Landi, Stefano; Zamparella, Maria; De Polo, Manuela; Boscariolo, Laura; Picchio, Marcello | |
Non invasive diagnosis of upper GI disease in a primary care setting: A study on 1900 patients | 1-gen-2017 | Di Mario, F.; Cesario, S.; Grillo, S.; Landi, S.; Baldassarre, G.; Cannizzaro, R.; Crafa, P.; Roberti, M.; Riccò, M.; Bertelè, A.; Corrente, V.; Scarpignato, C.; Rugge, M. | |
Optimal PPI-based triple therapy for the cure of Helicobacter pylori infection: a single center comparison of four 14-day schedules | 1-gen-1998 | Battaglia, G; Di Mario, F; Leandro, G; Benvenuti, M E; Donisi, P M; Vianello, F; Del Bò, N; Pasini, M; Pasquino, M; Vigneri, S | |
Pepsinogen II in gastritis and Helicobacter pylori infection | 1-gen-2022 | Di Mario, F.; Crafa, P.; Barchi, A.; Franzoni, L.; Franceschi, M.; Russo, M.; Bricca, L.; Brozzi, L.; Rodriguez Castro, K.; Rugge, M. | |
Practice pattern of gastroenterologists regarding the treatment of Helicobacter pylori infection in Italy | 1-gen-2017 | Zagari, R. M.; Eusebi, L. H.; Rabitti, S.; Annibale, B.; Caselli, M.; Di Mario, F.; Farinati, F.; Franceschi, F.; Gasbarrini, A.; Luzza, F.; Maconi, G.; Nardone, G.; Romano, M.; Vaira, B.; Bazzoli, F. | |
Raising public awareness of GI disease: An innovative strategy for a national campaign | 1-gen-2017 | Franzoni, L.; Crafa, P.; Bertelè, A.; Corrente, V.; Grillo, S.; Landi, S.; Miraglia, C.; Scida, S.; Di Mario, F. | |
Reflux esophagitis after H.p. eradication: A comparison between duodenal ulcer patients and control subjects | 1-gen-2017 | DI MARIO, Francesco | |
Role of homocysteine and chromogranin serum levels in chronic atrophic gastritis: Relationship with aetiology and severity according with olga staging | 1-gen-2017 | Panozzo, M.; Franceschi, M.; Baldassarre, G.; Miraglia, C.; Sella, D.; Antico, A.; Ferronato, A.; Scida, S.; Rugge, M.; Noto, A.; Crafa, P.; Scarpignato, C.; Franzoni, L.; Cannizzaro, R.; Tursi, A.; Di Mario, F. | |
Serum Pepsinogen II as a non-invasive marker for diagnosis of Helicobacter pylori infection: a prospective study in a cohort of dyspeptic patients | 1-gen-2017 | Di Mario, F.; Miraglia, C.; Scida, S.; Violi, A.; Cesario, S.; Franceschi, M.; Baldassarre, G.; Rugge, M.; Crafa, P.; Tursi, A.; Brandimarte, G.; Franzoni, L.; Cannizzaro, R.; Scarpignato, C. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile